Automate Your Wheel Strategy on MDLN
With Tiblio's Option Bot, you can configure your own wheel strategy including MDLN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MDLN
- Rev/Share 17.7877
- Book/Share 21.7769
- PB 2.0476
- Debt/Equity 0.9714
- CurrentRatio 3.6593
- ROIC 0.0325
- MktCap 36181135309.0
- FreeCF/Share 1.461
- PFCF 31.4619
- PE 53.5841
- Debt/Assets 0.4514
- DivYield 0
- ROE 0.0384
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | MDLN | Tigress Financial | -- | Buy | -- | $55 | Feb. 5, 2026 |
| Reiterated | MDLN | BTIG Research | -- | Buy | $50 | $55 | Jan. 21, 2026 |
| Initiation | MDLN | JP Morgan | -- | Overweight | -- | $50 | Jan. 12, 2026 |
| Initiation | MDLN | Mizuho | -- | Outperform | -- | $48 | Jan. 12, 2026 |
| Initiation | MDLN | Leerink Partners | -- | Outperform | -- | $48 | Jan. 12, 2026 |
| Initiation | MDLN | TD Cowen | -- | Buy | -- | $46 | Jan. 12, 2026 |
| Initiation | MDLN | BMO Capital Markets | -- | Outperform | -- | $45 | Jan. 12, 2026 |
| Initiation | MDLN | Evercore ISI | -- | Outperform | -- | $50 | Jan. 12, 2026 |
| Initiation | MDLN | Bernstein | -- | Outperform | -- | $49 | Jan. 12, 2026 |
| Initiation | MDLN | RBC Capital Mkts | -- | Outperform | -- | $47 | Jan. 12, 2026 |
News
Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway
Published: January 21, 2026 by: Seeking Alpha
Sentiment: Positive
Medline Industries (MDLN) earns a buy rating due to its robust vertically integrated model and scale-driven logistics advantages. MDLN's private label strategy enables margin expansion as contract wins accelerate, with signed FY2025 Prime Vendor contracts already doubling historical run rates. The company's logistics moat and cross-selling drive a virtuous cycle of market share gains and higher profitability, supporting durable growth.
Read More
The Biggest IPO of the Year Prompts Huge Insider Buy
Published: December 30, 2025 by: 24/7 Wall Street
Sentiment: Neutral
As the year winds down, many investors are positioning themselves for 2026 and beyond.
Read More
Boring companies are going public again, strong signal for 2026 IPOs: Axios' Primack
Published: December 17, 2025 by: CNBC Television
Sentiment: Positive
CNBC's "The Exchange" team discusses the IPO market, Medline's trading debut and more with Dan Primack, business editor at Axios.
Read More
KG on Significance of Oil Tanker Blockade, Medline's IPO & MU Earnings
Published: December 17, 2025 by: Schwab Network
Sentiment: Neutral
The story of the day goes to oil after a U.S. blockade of sanctioned Venezuelan oil tankers sent crude prices higher. Kevin Green explains how the story goes beyond oil.
Read More
About Medline Inc. (MDLN)
- IPO Date 2025-12-17
- Website https://www.medline.com
- Industry Medical - Instruments & Supplies
- CEO James Boyle
- Employees 43000